Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders


Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  KNBIF

Kane Biotech Inc is a biotechnology company engaged in research and development of products to prevent and disperse biofilms. Its products include DispersinB, Aledex, KBI Antibacterial Disinfectant, and StrixNB.
Price: $0.035 | Change: $0.00 | %Change: 0.00%
Volume: 251,000 | Day High/Low: 0.035/0.03 | 52 Week High/Low: 0.08/0.025
View modes: 
0 stars

FWIW, new CEO buys 1.1million shares

on the market since joining KNE in 3 months to July 24, at .03- .05.  See Insiders, top right.  rate and reply
0 stars


It is actually Georg that goes nasty because all I do is point out how stupid his posts about kne are. Don't expect sugar coating when his posts are wrong. All wrong always although because he more
0 stars

RE:RE:RE:RE:KNE left in the dust

Don't know why, but Burpfat continually misrepresents what I have written and adds to it, and spits on me.   He should google the "10 common cognitive errors" and observe how many he stumbles into. more
5 stars

RE:RE:RE:KNE left in the dust

shawshank wrote: BNF-you beat me to the post-BoyGeorge aka GeorgeMichaels (ya think he frequents public restrooms to?) likes to cloud pictures of clarity more
5 stars


Megantic mouths .... Let's wait for the next quarter and judge. The personal slags are just that. Nasty.  rate and reply
1 star

RE:RE:KNE left in the dust

BNF-you beat me to the post-BoyGeorge aka GeorgeMichaels (ya think he frequents public restrooms to?) likes to cloud pictures of clarity with more
2.5 stars

RE:RE:Now Now Georgie

Boy George-fallen?  Whereas what-you never were able to rise to the occassion in the first place. Seems you know the price of everything but the value of nothing. Pity-but not surprising-and if more
2 stars

RE:KNE left in the dust

George is having another apples and oranges Brain Fart that I must expose. His article is about big biotech companies followed by brokers and analysts but he thinks every biotech company is the more
0 stars

KNE left in the dust

I wonder if their decision to become a niche doggie company was wise in the long term. Well, they had reasons that looked good at the time. Zacks' Jason Napodano is not focused on a more
0 stars

RE:Anti-biofilm work at UBC

Thanks for the URL. That was aninteresting article (and series) to read.  Gives the bigger picture of KNE's competitive environment. Seems to me they are ahead of the pack, and might qualify for more
5 stars

RE:Now Now Georgie

All you have left to offer this board is correcting typos?  Kind of pathetic how far you've fallen.  rate and reply
3.5 stars

Insider buying, 1mil shares in past 3 months,

3 mil. bought in past year.  For who and how many in great detail, see "Insider", top right.  No sells listed  in a few years.  Not a lot, but a small insider vote of confidence. more
0 stars

Anti-biofilm work at UBC

One recent discovery in the fight against gram-negative bacteria came from research at the University of British Columbia. Researchers there discovered a peptide that can break up biofilms, more
1.5 stars

Now Now Georgie

Tell me BoyGeorge-is this a word from your last post in the English lanaguage or only within your invented use of vocabulary? Vis a vis "remended" as in you "remend" me of what? A sorcerer' more
0 stars

Boiler plate bumph, but worth reading carefully

The following comments are containted in notes attached to KNE's Q1 statement (Jan, Feb., Mar, 2015).  It's good to be remended of the precarious natue of penny stocks at this level, but also more
0.5 stars

RE:Twiddling thumbs, looking at numbers

"I think it's a mistake not to make it available online, but understand how that can torpedoe retail sales agreements." How many contradictory ideas can you claim in one sentence? Either they more
2.5 stars

RE:Twiddling thumbs, looking at numbers

The strategy is clear to all but you George. No need to rewrite everything for one dope who confuses the sp with operation success that have just started. The sp is a reflection of traders more
4 stars

Twiddling thumbs, looking at numbers

Without taking out a calculator, KNE has approx. 110mil shares outstanding. The sudden and disastrous drop from .08 one year ago to the .04 range has involved the exchange of ca. 40million more
0 stars

$.03 -- load up the wagons

and wait.  And wait.  rate and reply
0 stars

Quarter ends tomorrow

KNE doesn't usually make a quarterly report so you have to go looking *under Financials above. They must have cash to keep burning after raising $1,225,000 in the late-2014 PO, with about half of more